ANVS Market Cap History
Below is a table of the ANVS market cap history going back to 11/1/2021:

Date ANVS Market Cap
11/1/2021226.33M
2/28/2022115.93M
5/2/202281.31M

Also see: ANVS Shares Outstanding History
and ANVS YTD Return
ANVS Historical Market Cap:
-128.50% CAGR
ANVS Historical Market Cap: +-128.50% CAGR

Mouse over chart for data details
11/1/20212/28/20225/2/2022
Annovis Bio is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's disease in Down syndrome (AD-DS). Co.'s pipeline consists of: ANVS401, which is an orally administered drug being developed for chronic indications such as AD, PD and AD-DS by inhibiting the overproduction of neurotoxic proteins that kill nerve cells; ANVS405, which is focused on protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which increases cognitive capability in later stages of AD and dementia. We show 3 historical shares outstanding datapoints in our ANVS shares outstanding history coverage, used to compute ANVS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ANVS market cap history over the course of time is important for investors interested in comparing ANVS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ANVS versus a peer is one thing; comparing ANVS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ANVS can fluctuate over the course of history. With this page we aim to empower investors researching ANVS by allowing them to research the ANVS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ANVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Annovis Bio (ANVS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

APDN Market Cap History
APEN Market Cap History
APLS Market Cap History
APLT Market Cap History
APR Market Cap History
APRE Market Cap History
APRI Market Cap History
APTX Market Cap History
APVO Market Cap History
APYX Market Cap History
More Healthcare companies »

 

ANVS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.